Home/Filings/4/0000821616-05-000007
4//SEC Filing

BENTLEY PHARMACEUTICALS INC 4

Accession 0000821616-05-000007

CIK 0000821616operating

Filed

May 24, 8:00 PM ET

Accepted

May 25, 1:05 PM ET

Size

15.3 KB

Accession

0000821616-05-000007

Insider Transaction Report

Form 4
Period: 2005-05-24
Transactions
  • Award

    Right to purchase

    2005-05-24+20,00020,000 total
    Exercise: $10.79Exp: 2015-05-24Common Stock, $.02 par value (20,000 underlying)
Holdings
  • Common Stock, $.02 par value

    12,968
  • Right to purchase

    Exercise: $11.71Exp: 2012-05-22Common Stock, $.02 par value (30,000 underlying)
    30,000
  • Right to purchase

    Exercise: $10.04Exp: 2013-05-21Common Stock, $.02 par value (20,000 underlying)
    20,000
  • Right to purchase

    Exercise: $3.00Exp: 2009-06-30Common Stock, $.02 par value (16,900 underlying)
    16,900
  • Right to purchase

    Exercise: $6.00Exp: 2011-05-09Common Stock, $.02 par value (27,900 underlying)
    27,900
  • Right to purchase

    Exercise: $7.25Exp: 2010-06-09Common Stock, $.02 par value (27,300 underlying)
    27,300
Footnotes (7)
  • [F1]Options were granted under terms of the Company's 1991 Stock Option Plan as remuneration for services as a member of the Board of Directors. Grant became exercisable on 6/30/2000.
  • [F2]Options were granted under terms of the Company's 1991 Stock Option Plan as remuneration for services as a member of the Board of Directors. Grant became exercisable on 6/9/2001.
  • [F3]Options were granted under terms of the Company's 2001 Directors' Stock Option Plan as remuneration for services as a member of the Board of Directors. Grant became exercisable on 5/9/2002.
  • [F4]Options were granted under terms of the Company's 2001 Directors' Stock Option Plan as remuneration for services as a member of the Board of Directors. Grant became exercisable in two equal installments on 5/22/2003 and 5/22/2004.
  • [F5]Options were granted under terms of the Company's 2001 Directors' Stock Option Plan as remuneration for services as a member of the Board of Directors. Grant became exercisable in four equal installments on 7/31/2003, 10/31/2003, 1/31/2004 and 4/30/2004.
  • [F6]Options were granted under terms of the Company's 2001 Directors' Stock Option Plan as remuneration for services as a member of the Board of Directors. Grant became exercisable in four equal installments on 7/31/2004, 10/31/2004, 1/31/2005 and 4/30/2005.
  • [F7]Options were granted under terms of the Company's 2005 Equity and Incentive Plan as remuneration for services as a member of the Board of Directors. Grant becomes exercisable in four equal installments on 7/31/2005, 10/31/2005, 1/31/2006 and 4/30/2006.

Issuer

BENTLEY PHARMACEUTICALS INC

CIK 0000821616

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000821616

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 1:05 PM ET
Size
15.3 KB